CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenue
Total revenue, net	$ 3,083	$ 3,108	$ 8,276	$ 8,180
Operating expenses
Cost of product revenue	532	541	1,574	1,398
Research and development	3,658	4,043	10,653	12,008
Sales and marketing	1,997	2,010	6,957	4,977
General and administrative	4,134	3,776	13,758	12,471
Total operating expenses	10,321	10,370	32,942	30,854
Loss from operations	(7,238)	(7,262)	(24,666)	(22,674)
Gain (loss) on extinguishment of debt			(1,822)	1,245
Changes in fair value of freestanding and hybrid financial instruments designated at Fair Value Option	(2,310)	(3,089)	(4,721)	(6,920)
Interest income (expense)	(6)	162	65	(341)
Other income (expense)	(94)	168	340	(327)
Loss before income tax expense	(9,648)	(10,021)	(30,804)	(29,017)
Net loss	(9,648)	(10,021)	(30,804)	(29,017)
Net loss attributable to noncontrolling interest	(146)	(167)	(431)	(445)
Net loss attributable to common stockholders	$ (9,502)	$ (9,854)	$ (30,373)	$ (28,572)
Net loss per share, basic	$ (6.28)	$ (26.29)	$ (22.61)	$ (150.72)
Net loss per share, diluted	$ (6.28)	$ (26.29)	$ (22.61)	$ (150.72)
Weighted-average common stock outstanding, basic	1,513,178	374,805	1,343,443	189,567
Weighted-average common stock outstanding, diluted	1,513,178	374,805	1,343,443	189,567
Product revenue, net
Revenue
Total revenue, net	$ 3,041	$ 3,066	$ 8,148	$ 8,095
License revenue
Revenue
Total revenue, net	$ 42	$ 42	$ 128	$ 85